ReviewInternational journal of molecular sciences2021

SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.

Mercedes Unzeta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.